Dexamethasone
2017[1359]-2
Approved small_molecule terminated
Quick answer
Dexamethasone for Carcinoma, Non-Small-Cell Lung is a Approved program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Carcinoma, Non-Small-Cell Lung
- Phase
- Approved
- Modality
- small_molecule
- Status
- terminated